Microphysiological Engineering of Self-Assembled and Perfusable Microvascular Beds for the Production of Vascularized Three-Dimensional Human Microtissues

Jungwook Paek(University of Pennsylvania), Sunghee Estelle Park(University of Pennsylvania), Qiaozhi Lu(University of Pennsylvania), Kyu-Tae Park(University of Pennsylvania), Minseon Cho(University of Pennsylvania), Jeong Min Oh(University of Pennsylvania), Keon Woo Kwon(University of Pennsylvania), Yoon‐Suk Yi(University of Pennsylvania), Joseph W. Song(University of Pennsylvania), Hailey I. Edelstein(California Institute for Regenerative Medicine), Jeff Ishibashi(University of Pennsylvania), Wenli Yang(California Institute for Regenerative Medicine), Jacob W. Myerson(Target (United States)), Raisa Y. Kiseleva(Target (United States)), Pavel Aprelev(Target (United States)), Elizabeth D. Hood(Target (United States)), Dwight Stambolian(University of Pennsylvania), Patrick Seale(University of Pennsylvania), Vladimir R. Muzykantov(Target (United States)), Dongeun Huh(University of Pennsylvania)
ACS Nano
June 13, 2019
Cited by 235

Abstract

formation, anastomosis, and controlled perfusion of 3D vascular networks. An open-top chamber design adopted in this hybrid platform also makes it possible to integrate the microengineered 3D vasculature with other cell types to recapitulate organ-specific cellular heterogeneity and structural organization of vascularized human tissues. Using these capabilities, we developed stem cell-derived microphysiological models of vascularized human adipose tissue and the blood-retinal barrier. Our approach was also leveraged to construct a 3D organotypic model of vascularized human lung adenocarcinoma as a high-content drug screening platform to simulate intravascular delivery, tumor-killing effects, and vascular toxicity of a clinical chemotherapeutic agent. Furthermore, we demonstrated the potential of our platform for applications in nanomedicine by creating microengineered models of vascular inflammation to evaluate a nanoengineered drug delivery system based on active targeting liposomal nanocarriers. These results represent a significant improvement in our ability to model the complexity of native human tissues and may provide a basis for developing predictive preclinical models for biopharmaceutical applications.


Related Papers

No related papers found

Powered by citation graph analysis